GLP-1-based therapies for diabetes, obesity and beyond
In the area of voice and video calls Mobees provides a highly-scalable SIP Call Router and Call Media Processor for real-time media stream processing to enable innovative telecommunication services
Why are therapeutic injection claims frequently denied
Within the pancreas, GIP and GLP-1 together promote -cell proliferation and inhibit cell death, thereby resulting in pancreatic -cell mass-increase, while GIP enhances postprandial glucagon response and GLP-1 suppresses it [9, 10]
Our laboratory experiments showed that the pomegranate extract can reduce the production of TMA
For patients with severe obesity or obesity-associated comorbidities, this difference can be clinically meaningful, reinforcing the preference for injectable therapies in high-risk patient populations